Corporate Partnership Programme
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
EMBL boasts some of the best scientific talent in Europe. Get in touch.
The European Molecular Biology Laboratory employs some of the greatest minds in European science. Our talent pool boasts biologists, engineers, IT professionals and countless other scientific specialisations. In addition, EMBL research has many practical and industrial applications
We harness EMBL’s entrepreneurial spirit through technology transfer programmes and technology spin-offs.
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). Established in 1999, EMBLEM identifies, protects and commercialises the intellectual property developed at EMBL, by EMBL alumni and by non-EMBL third parties. EMBLEM works closely with industrial partners in the biotech, IT and engineering markets to accelerate the transfer of innovative technology from basic research to industry.
EMBLEM manages a portfolio of close to 300 individual patents, patent applications, copyrights, trademarks and utility models. The technology portfolio, which spans the life sciences, includes enabling technologies, scientific instruments, molecular tools and techniques, as well as software programmes and databases.
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
A forum for interaction and knowledge exchange for those employed at the forefront of industrial bioinformatics.
A freely-available, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
The Agri-Tech Partnership establishes collaboration with domain experts in advanced agricultural technologies from both public and private sectors.
Based in Heidelberg, Germany, EMBL Ventures invest throughout Europe to build companies that create significant commercial opportunities based on new therapeutic-treatment modalities and pharmaceuticals, next-generation enabling-technology platforms or innovations in the diagnostics and medical device area.
As an independent and focused team, EMBL Ventures moves quickly with short decision timelines.
Industry news from EMBL’s six sites
Alumnus Norbert Kraut reflects on how his time at EMBL led to his successes in addressing hard-to-treat lung cancer.
Edit
EMBL alumnus and Lennart Philipson Awardee Florent Cipriani reflects on his 30 years at EMBL Grenoble and his multidisciplinary career building technologies that enable new discoveries.
Edit
EMBL-EBI receives UKRI Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR) funding for enhancing and translating mental-health omics data into the Open Targets Pl…
EditDo you want to lead groundbreaking research in computational biology? Join us at EMBL-EBI!EMBL's European Bioinformatics Institute (EMBL-EBI) is seeking talented and highly-motivated scientists to join its Faculty and develop their own independent research group. We welcome applicants from across th...
Closes on 12th April. Posted 29th January 2026
EditEMBL is Europe’s life sciences laboratory – an intergovernmental organisation with more than 110 independent research groups and service teams covering the spectrum of molecular biology. It operates across six sites in Heidelberg (headquarters), Barcelona, Cambridge, Grenoble, Hamburg and Rome. Our...
Closes on 3rd March. Posted 29th January 2026
EditEMBL is seeking an experienced and motivated Workday Team Leader to lead the delivery, optimisation, and ongoing support of the Workday platform across the organisation. As EMBL transitions to a full Workday platform by the end of 2026, this role will play a key part in ensuring Workday reliably sup...
Closes on 14th February. Posted 29th January 2026
EditWith support from more than 30 countries, laboratories at six sites across Europe and thousands of scientists and engineers working together, the European Molecular Biology Laboratory (EMBL) is a powerhouse of biological expertise. EMBL is an intergovernmental organisation, headquartered in Heidelberg, and was founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies.
EMBL currently employs more than 1800 people in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton (near Cambridge), and Rome.
Publishing hundreds of research articles and hosting dozens of conferences every year, EMBL is driving visionary fundamental research and training Europe’s future scientific talent.